Authors:
Sander, T
Schulz, H
Saar, K
Gennaro, E
Riggio, MC
Bianchi, A
Zara, F
Luna, D
Bulteau, C
Kaminska, A
Ville, D
Cieuta, C
Picard, F
Prud'homme, JF
Bate, L
Sundquist, A
Gardiner, RM
Janssen, GAMAJ
de Haan, GJ
Kasteleijn-Nolst-Trenite, DGA
Bader, A
Lindhout, D
Riess, O
Wienker, TF
Janz, D
Reis, A
Citation: T. Sander et al., Genome search for susceptibility loci of common idiopathic generalised epilepsies, HUM MOL GEN, 9(10), 2000, pp. 1465-1472
Authors:
Sander, T
Berlin, W
Gscheidel, N
Wendel, B
Janz, D
Hoehe, MR
Citation: T. Sander et al., Genetic variation of the human mu-opioid receptor and susceptibility to idiopathic absence epilepsy, EPILEPSY R, 39(1), 2000, pp. 57-61
Authors:
Shorvon, SD
Lowenthal, A
Janz, D
Bielen, E
Loiseau, P
Citation: Sd. Shorvon et al., Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures, EPILEPSIA, 41(9), 2000, pp. 1179-1186
Authors:
Sander, T
Syagailo, Y
Samochowiec, J
Okladnova, O
Lesch, KP
Janz, D
Citation: T. Sander et al., Association analysis of a regulatory promoter polymorphism of the PAX-6 gene with idiopathic generalized epilepsy, EPILEPSY R, 36(1), 1999, pp. 61-67
Authors:
Sander, T
Scholz, L
Janz, D
Epplen, JT
Riess, O
Citation: T. Sander et al., Length variation of a polyglutamine array in the gene encoding a small-conductance, calcium-activated potassium channel (hKCa3) and susceptibility toidiopathic generalized epilepsy, EPILEPSY R, 33(2-3), 1999, pp. 227-233
Authors:
Sander, T
Schulz, H
Vieira-Saeker, AMM
Bianchi, AM
Sailer, U
Bauer, G
Scaramelli, A
Wienker, TF
Saar, K
Reis, A
Janz, D
Epplen, JT
Riess, O
Citation: T. Sander et al., Evaluation of a putative major susceptibility locus for juvenile myoclonicepilepsy on chromosome 15q14, AM J MED G, 88(2), 1999, pp. 182-187